ExodusPoint Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $550K | Sell |
58,609
-29,043
| -33% | -$273K | ﹤0.01% | 1065 |
|
|
2025
Q1 | $623K | Sell |
87,652
-18,175
| -17% | -$129K | 0.01% | 1006 |
|
|
2024
Q4 | $1.23M | Buy |
105,827
+52,486
| +98% | +$612K | 0.01% | 809 |
|
|
2024
Q3 | $1.1M | Buy |
+53,341
| New | +$1.1M | 0.01% | 890 |
|
|
2024
Q2 | – | Sell |
-80,752
| Closed | -$2.22M | – | 1695 |
|
|
2024
Q1 | $2.22M | Buy |
80,752
+13,500
| +20% | +$371K | 0.02% | 559 |
|
|
2023
Q4 | $2.05M | Buy |
67,252
+35,816
| +114% | +$1.09M | 0.01% | 527 |
|
|
2023
Q3 | $994K | Buy |
31,436
+24,178
| +333% | +$765K | 0.01% | 932 |
|
|
2023
Q2 | $296K | Buy |
+7,258
| New | +$296K | ﹤0.01% | 1460 |
|
|
2023
Q1 | – | Sell |
-9,982
| Closed | -$348K | – | 1918 |
|
|
2022
Q4 | $348K | Sell |
9,982
-7,204
| -42% | -$251K | 0.01% | 1259 |
|
|
2022
Q3 | $962K | Buy |
17,186
+9,283
| +117% | +$520K | 0.01% | 1091 |
|
|
2022
Q2 | $409K | Sell |
7,903
-9,340
| -54% | -$483K | 0.01% | 1384 |
|
|
2022
Q1 | $1.25M | Buy |
+17,243
| New | +$1.25M | 0.02% | 966 |
|
|
2021
Q4 | – | Sell |
-3,467
| Closed | -$465K | – | 2408 |
|
|
2021
Q3 | $465K | Buy |
+3,467
| New | +$465K | 0.01% | 1393 |
|
|
2021
Q1 | – | Sell |
-9,134
| Closed | -$497K | – | 2386 |
|
|
2020
Q4 | $497K | Sell |
9,134
-45,589
| -83% | -$2.48M | ﹤0.01% | 1185 |
|
|
2020
Q3 | $1.09M | Buy |
54,723
+15,841
| +41% | +$315K | 0.02% | 599 |
|
|
2020
Q2 | $817K | Buy |
+38,882
| New | +$817K | 0.02% | 823 |
|
|
2019
Q4 | – | Sell |
-13,089
| Closed | -$175K | – | 1718 |
|
|
2019
Q3 | $175K | Buy |
+13,089
| New | +$175K | 0.01% | 1129 |
|